Vilya is a computational biotechnology company creating a novel class of medicines to precisely target disease biology. We believe computational approaches are an integral, if not foundational, component of drug discovery and development. Our plat...
In House Counsel Jobs | JDHuntr 49607 Senior Counsel Intellectual Property, San Francisco, CA
To apply go to JDHuntr.com
Take the leading role in the ongoing design of companys intellectual property portfolio development strategy including samp...
If you are a Lab Assistant with some experience, please read on!
Job Title: Lab Assistant
Location: South San Francisco, CA
Requirements: B.S. in Biology, Chemistry or Physics / 1+ year of relevant experience in an academic lab (classes ...
Job description
Arsenal Bio, a privately held programmable cell therapy company engineering advanced CAR T therapies for solid tumors, is seeking a talented Sr. Clinical Trial Management Associate (Sr. CTMA) to work remotely.
ArsenalBioâs m...
The Biologics CMC Development team at AbbVie in the Bay Area has a long and rich history of biologics development . Now located in a new state of the art facility in South San Francisco, the team leverages its comprehensive end-to-end CMC ...
At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically-relevant protein homeostatic mechanisms to regulate genetically-validated targets.
As Senior/Principal Scientist, Proteomics you ...
Biomarker Research Scientist
Denali Therapeutics, South San Francisco, USA
Denali Therapeutics is dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of tr...
The Biologics CMC Development team at AbbVie in the Bay Area has a long and rich history of biologics development. Now located in a new state of the art facility in South San Francisco, the team leverages its comprehensive end-to-end CMC capabilit...
ALX Oncology Inc. (ALX) is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway. Our lead candidate, evorpacept (ALX148), is a next generation CD47 blocking ...
